RB1 and cancer: Deletions of genome in some cancers could lead to inactivation of cancer suppressor genes like RB1, P16, PTEN, etc. While genome amplification could activate some cancer promoter genes, like MYC, ERBB2, EGFR, etc. Those genes have important roles in many pathways that could promote or suppress cellular behaviors [33].